Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Haridas B. Rode"'
Publikováno v:
Acta Crystallographica Section E, Vol 68, Iss 10, Pp o2951-o2952 (2012)
The title nitrothiophene compound, C13H9N3O6S2, crystallizes with two independent molecules in the asymmetric unit; the molecular structure of each is stabilized by an intramolecular N—H...O hydrogen bond. The two molecules adopt flattened but slig
Externí odkaz:
https://doaj.org/article/b664da62d01246c49971fa5d91af49dd
Autor:
Thrilokraj R., Rajeev V. Hegde, Arnab Ghosh, Akshay S. Limaye, Haridas B. Rode, Balasubramanian Sridhar, Ramesh B. Dateer
Publikováno v:
New Journal of Chemistry. 47:8268-8276
A sustainable and environmentally benign biogenic technique for one-step synthesis of Ni-NPs (NiC2O4·2H2O-NPs) using Portulaca oleracea (purslane) leaf extract has been disclosed for the first time.
Autor:
Grace Kaul, Uttam B Karale, Abdul Akhir, Manjulika Shukla, Deepanshi Saxena, Haridas B Rode, Sidharth Chopra
Publikováno v:
Future Microbiology. 17:1475-1486
Background: Drug repurposing is a viable approach to expediting the tedious conventional drug discovery process, given rapidly increasing bacterial resistance. In this context, we have repurposed pyrvinium pamoate (PP) for its antibacterial activity
Autor:
Gangarajula Sudhakar, Chennam Ramu, T. Kumaraguru, M. Sridhar Reddy, Haridas B. Rode, Subhash Ghosh, Ch. Raji Reddy
Publikováno v:
Synthesis.
We have designed and developed an easily accessible advanced intermediate of ledipasvir that allowed late-stage cyclopropanation and difluorination, thereby providing a novel and more efficient process for the preparation of ledipasvir in the longest
Autor:
Daniel Rauh, Roman K. Thomas, Heidi Greulich, Tzu-Hsiu Chen, Yuki Yuza, Matthäus Getlik, Jeffrey R. Simard, Mirjam Koker, Matthias Rabiller, Lars Ruddigkeit, Jonathan Weiss, Johannes M. Heuckmann, Cecile Reuter, Vijaykumar G. Pawar, Sabine Klüter, Florian Fischer, Martin Peifer, Stefanie Heynck, Haridas B. Rode, Martin L. Sos
Supplementary Figure 2 from Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b33c46cc59f5c4a05c14a3e2762176c
https://doi.org/10.1158/0008-5472.22385273.v1
https://doi.org/10.1158/0008-5472.22385273.v1
Autor:
Daniel Rauh, Roman K. Thomas, Heidi Greulich, Tzu-Hsiu Chen, Yuki Yuza, Matthäus Getlik, Jeffrey R. Simard, Mirjam Koker, Matthias Rabiller, Lars Ruddigkeit, Jonathan Weiss, Johannes M. Heuckmann, Cecile Reuter, Vijaykumar G. Pawar, Sabine Klüter, Florian Fischer, Martin Peifer, Stefanie Heynck, Haridas B. Rode, Martin L. Sos
Supplementary Figure 4 from Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c3adab8e6719a4afeccf3c429f681c
https://doi.org/10.1158/0008-5472.22385267.v1
https://doi.org/10.1158/0008-5472.22385267.v1
Autor:
Daniel Rauh, Roman K. Thomas, Heidi Greulich, Tzu-Hsiu Chen, Yuki Yuza, Matthäus Getlik, Jeffrey R. Simard, Mirjam Koker, Matthias Rabiller, Lars Ruddigkeit, Jonathan Weiss, Johannes M. Heuckmann, Cecile Reuter, Vijaykumar G. Pawar, Sabine Klüter, Florian Fischer, Martin Peifer, Stefanie Heynck, Haridas B. Rode, Martin L. Sos
Reversible epidermal growth factor receptor (EGFR) inhibitors are the first class of small molecules to improve progression-free survival of patients with EGFR-mutated lung cancers. Second-generation EGFR inhibitors introduced to overcome acquired re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c57476dbb8bceb81527d4a605d7f2ff
https://doi.org/10.1158/0008-5472.c.6501170.v1
https://doi.org/10.1158/0008-5472.c.6501170.v1
Autor:
Daniel Rauh, Roman K. Thomas, Heidi Greulich, Tzu-Hsiu Chen, Yuki Yuza, Matthäus Getlik, Jeffrey R. Simard, Mirjam Koker, Matthias Rabiller, Lars Ruddigkeit, Jonathan Weiss, Johannes M. Heuckmann, Cecile Reuter, Vijaykumar G. Pawar, Sabine Klüter, Florian Fischer, Martin Peifer, Stefanie Heynck, Haridas B. Rode, Martin L. Sos
Supplementary Figure 3 from Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dda31a666e50397a900ef397d1a01dd
https://doi.org/10.1158/0008-5472.22385270.v1
https://doi.org/10.1158/0008-5472.22385270.v1
Autor:
Daniel Rauh, Roman K. Thomas, Heidi Greulich, Tzu-Hsiu Chen, Yuki Yuza, Matthäus Getlik, Jeffrey R. Simard, Mirjam Koker, Matthias Rabiller, Lars Ruddigkeit, Jonathan Weiss, Johannes M. Heuckmann, Cecile Reuter, Vijaykumar G. Pawar, Sabine Klüter, Florian Fischer, Martin Peifer, Stefanie Heynck, Haridas B. Rode, Martin L. Sos
Supplementary Figure 1 from Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::417bb50b9082366c7e5acc04c42b3a1e
https://doi.org/10.1158/0008-5472.22385276
https://doi.org/10.1158/0008-5472.22385276
Autor:
Daniel Rauh, Roman K. Thomas, Heidi Greulich, Tzu-Hsiu Chen, Yuki Yuza, Matthäus Getlik, Jeffrey R. Simard, Mirjam Koker, Matthias Rabiller, Lars Ruddigkeit, Jonathan Weiss, Johannes M. Heuckmann, Cecile Reuter, Vijaykumar G. Pawar, Sabine Klüter, Florian Fischer, Martin Peifer, Stefanie Heynck, Haridas B. Rode, Martin L. Sos
Supplementary Methods, Figure Legends 1-3 from Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b08756303c46561e6b36ae101b44aab
https://doi.org/10.1158/0008-5472.22385264.v1
https://doi.org/10.1158/0008-5472.22385264.v1